• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of annrheumdAnnals of the Rheumatic DiseasesCurrent TOCInstructions for authors
Ann Rheum Dis. Sep 2002; 61(9): 804–809.
PMCID: PMC1754213

Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis

Abstract

Background: Cell adhesion molecules and endothelial growth factors have an important role in the infiltrating of rheumatoid synovium with mononuclear cells, leading to the initiation and progression of the disease.

Objective: To investigate whether the serum profile of soluble adhesion molecules and of vascular endothelial growth factor (VEGF) is associated with the histological appearance of rheumatoid arthritis (RA).

Methods: Serum levels of soluble intercellular adhesion molecule-1 (sICAM-1), vascular cell adhesion molecule-1 (sVCAM-1), E-selectin (sE-selectin), and VEGF were assessed by enzyme linked immunosorbent assay (ELISA) in 40 patients with RA and 32 patients with osteoarthritis (OA).

Results: Histological analysis of synovium specimens distinguished two types of rheumatoid synovitis. Twenty four RA samples presented diffuse infiltrates of mononuclear cells without any further microanatomical organisation, whereas in the remaining 16 samples lymphocytic follicles with germinal centre-like structures were identified. In comparison with patients with OA, constituting a control group, higher serum concentrations of sICAM-1 (p<0.001), sVCAM-1 (p<0.001), sE-selectin (p<0.01), and VEGF (p<0.001) were detected in patients with RA. Raised concentrations of sICAM-1, sVCAM-1, and VEGF dominated in the serum of patients with RA with follicular synovitis compared with those with diffuse synovitis (p<0.01 for all comparisons). The serum concentrations of sICAM-1, sVCAM-1, and VEGF correlated with markers of disease activity such as the erythrocyte sedimentation rate and C reactive protein levels. Furthermore, the clinical data analysed in our study indicated that patients with RA with follicular synovitis tend to have more severe disease.

Conclusions: The distinct histological appearances of rheumatoid synovitis associated with different serum profiles of sICAM-1, sVCAM-1, and VEGF reflect varied clinical activity of the disease and confirm RA heterogeneity. Patients with different histological forms of synovitis may respond differently to the treatment regimens.

Full Text

The Full Text of this article is available as a PDF (165K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Tak PP, Bresnihan B. The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis. Arthritis Rheum. 2000 Dec;43(12):2619–2633. [PubMed]
  • Young CL, Adamson TC, 3rd, Vaughan JH, Fox RI. Immunohistologic characterization of synovial membrane lymphocytes in rheumatoid arthritis. Arthritis Rheum. 1984 Jan;27(1):32–39. [PubMed]
  • Yanni G, Whelan A, Feighery C, Quinlan W, Symons J, Duff G, Bresnihan B. Contrasting levels of in vitro cytokine production by rheumatoid synovial tissues demonstrating different patterns of mononuclear cell infiltration. Clin Exp Immunol. 1993 Sep;93(3):387–395. [PMC free article] [PubMed]
  • Klimiuk PA, Goronzy JJ, Björ nsson J, Beckenbaugh RD, Weyand CM. Tissue cytokine patterns distinguish variants of rheumatoid synovitis. Am J Pathol. 1997 Nov;151(5):1311–1319. [PMC free article] [PubMed]
  • Kim HJ, Krenn V, Steinhauser G, Berek C. Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis. J Immunol. 1999 Mar 1;162(5):3053–3062. [PubMed]
  • Takemura S, Klimiuk PA, Braun A, Goronzy JJ, Weyand CM. T cell activation in rheumatoid synovium is B cell dependent. J Immunol. 2001 Oct 15;167(8):4710–4718. [PubMed]
  • Malone DG, Wahl SM, Tsokos M, Cattell H, Decker JL, Wilder RL. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. J Clin Invest. 1984 Oct;74(4):1173–1185. [PMC free article] [PubMed]
  • Rooney M, Condell D, Quinlan W, Daly L, Whelan A, Feighery C, Bresnihan B. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum. 1988 Aug;31(8):956–963. [PubMed]
  • Sany J. Clinical and biological polymorphism of rheumatoid arthritis. Clin Exp Rheumatol. 1994 Nov-Dec;12 (Suppl 11):S59–S61. [PubMed]
  • Weyand CM, Klimiuk PA, Goronzy JJ. Heterogeneity of rheumatoid arthritis: from phenotypes to genotypes. Springer Semin Immunopathol. 1998;20(1-2):5–22. [PubMed]
  • Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Serum cytokines in different histological variants of rheumatoid arthritis. J Rheumatol. 2001 Jun;28(6):1211–1217. [PubMed]
  • Klimiuk PA, Sierakowski S, Latosiewicz R, Cylwik B, Skowronski J, Chwiecko J. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in different histological variants of rheumatoid synovitis. Rheumatology (Oxford) 2002 Jan;41(1):78–87. [PubMed]
  • Klimiuk PA, Yang H, Goronzy JJ, Weyand CM. Production of cytokines and metalloproteinases in rheumatoid synovitis is T cell dependent. Clin Immunol. 1999 Jan;90(1):65–78. [PubMed]
  • Blann AD, Herrick A, Jayson MI. Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol. 1995 Sep;34(9):814–819. [PubMed]
  • McMurray RW. Adhesion molecules in autoimmune disease. Semin Arthritis Rheum. 1996 Feb;25(4):215–233. [PubMed]
  • Mojcik CF, Shevach EM. Adhesion molecules: a rheumatologic perspective. Arthritis Rheum. 1997 Jun;40(6):991–1004. [PubMed]
  • Tokuhira M, Hosaka S, Volin MV, Haines GK, 3rd, Katschke KJ, Jr, Kim S, Koch AE. Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum. 2000 May;43(5):1122–1133. [PubMed]
  • Paleolog EM. Angiogenesis: a critical process in the pathogenesis of RA--a role for VEGF? Br J Rheumatol. 1996 Oct;35(10):917–919. [PubMed]
  • Brenchley PE. Antagonising angiogenesis in rheumatoid arthritis. Ann Rheum Dis. 2001 Nov;60 (Suppl 3):iii71–iii74. [PMC free article] [PubMed]
  • Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature. 1995 Aug 10;376(6540):517–519. [PubMed]
  • Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. [PubMed]
  • Ritchie DM, Boyle JA, McInnes JM, Jasani MK, Dalakos TG, Grieveson P, Buchanan WW. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed]
  • STEINBROCKER O, TRAEGER CH, BATTERMAN RC. Therapeutic criteria in rheumatoid arthritis. J Am Med Assoc. 1949 Jun 25;140(8):659–662. [PubMed]
  • Szekanecz Z, Haines GK, Lin TR, Harlow LA, Goerdt S, Rayan G, Koch AE. Differential distribution of intercellular adhesion molecules (ICAM-1, ICAM-2, and ICAM-3) and the MS-1 antigen in normal and diseased human synovia. Their possible pathogenetic and clinical significance in rheumatoid arthritis. Arthritis Rheum. 1994 Feb;37(2):221–231. [PubMed]
  • Tak PP, Thurkow EW, Daha MR, Kluin PM, Smeets TJ, Meinders AE, Breedveld FC. Expression of adhesion molecules in early rheumatoid synovial tissue. Clin Immunol Immunopathol. 1995 Dec;77(3):236–242. [PubMed]
  • Mason JC, Kapahi P, Haskard DO. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Lack of correlation with levels of circulating vascular cell adhesion molecule 1. Arthritis Rheum. 1993 Apr;36(4):519–527. [PubMed]
  • Carter RA, Wicks IP. Vascular cell adhesion molecule 1 (CD106): a multifaceted regulator of joint inflammation. Arthritis Rheum. 2001 May;44(5):985–994. [PubMed]
  • Kuryliszyn-Moskal A, Bernacka K, Klimiuk PA. Circulating intercellular adhesion molecule 1 in rheumatoid arthritis--relationship to systemic vasculitis and microvascular injury in nailfold capillary microscopy. Clin Rheumatol. 1996 Jul;15(4):367–373. [PubMed]
  • Littler AJ, Buckley CD, Wordsworth P, Collins I, Martinson J, Simmons DL. A distinct profile of six soluble adhesion molecules (ICAM-1, ICAM-3, VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol. 1997 Feb;36(2):164–169. [PubMed]
  • Veale DJ, Maple C, Kirk G, McLaren M, Belch JJ. Soluble cell adhesion molecules--P-selectin and ICAM-1, and disease activity in patients receiving sulphasalazine for active rheumatoid arthritis. Scand J Rheumatol. 1998;27(4):296–299. [PubMed]
  • Nassonov EL, Samsonov MY, Chichasova NV, Nikiphorova EL, Tilz GP, Demel U, Widner B, Fuchs D. Soluble adhesion molecules in rheumatoid arthritis. Rheumatology (Oxford) 2000 Jul;39(7):808–810. [PubMed]
  • Aoki S, Imai K, Yachi A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol. 1993 Nov;38(5):485–490. [PubMed]
  • Voskuyl AE, Martin S, Melchers L, Zwinderman AH, Weichselbraun I, Breedveld FC. Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leucocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol. 1995 Apr;34(4):311–315. [PubMed]
  • Cush JJ, Rothlein R, Lindsley HB, Mainolfi EA, Lipsky PE. Increased levels of circulating intercellular adhesion molecule 1 in the sera of patients with rheumatoid arthritis. Arthritis Rheum. 1993 Aug;36(8):1098–1102. [PubMed]
  • Janssen BA, Luqmani RA, Gordon C, Hemingway IH, Bacon PA, Gearing AJ, Emery P. Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis. Br J Rheumatol. 1994 Dec;33(12):1112–1116. [PubMed]
  • Wellicome SM, Kapahi P, Mason JC, Lebranchu Y, Yarwood H, Haskard DO. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol. 1993 Jun;92(3):412–418. [PMC free article] [PubMed]
  • To SS, Newman PM, Hyland VJ, Robinson BG, Schrieber L. Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum. 1996 Mar;39(3):467–477. [PubMed]
  • Ferrara N. Leukocyte adhesion. Missing link in angiogenesis. Nature. 1995 Aug 10;376(6540):467–467. [PubMed]
  • Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W. Soluble E-selectin is increased in inflammatory synovial fluid. J Rheumatol. 1994 Apr;21(4):605–611. [PubMed]
  • Harada M, Mitsuyama K, Yoshida H, Sakisaka S, Taniguchi E, Kawaguchi T, Ariyoshi M, Saiki T, Sakamoto M, Nagata K, et al. Vascular endothelial growth factor in patients with rheumatoid arthritis. Scand J Rheumatol. 1998;27(5):377–380. [PubMed]
  • Paleolog EM, Young S, Stark AC, McCloskey RV, Feldmann M, Maini RN. Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor alpha and interleukin-1 in rheumatoid arthritis. Arthritis Rheum. 1998 Jul;41(7):1258–1265. [PubMed]
  • Kikuchi K, Kubo M, Kadono T, Yazawa N, IHN H, Tamaki K. Serum concentrations of vascular endothelial growth factor in collagen diseases. Br J Dermatol. 1998 Dec;139(6):1049–1051. [PubMed]
  • Lee SS, Joo YS, Kim WU, Min DJ, Min JK, Park SH, Cho CS, Kim HY. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001 May-Jun;19(3):321–324. [PubMed]

Figures and Tables

Figure 1
Histological pictures of RA and OA synovia. Representative samples are presented for the groups of patients analysed. (A) RA synovium specimen displaying diffuse mononuclear cell infiltrates without specific microanatomical organisation. (B) RA sample ...
Figure 2
Serum concentrations of sICAM-1 in the patients studied. Assessment was based on an ELISA technique. The box plots represent median (line), 25th and 75th centiles (box), and 10th and 90th centiles (whiskers).
Figure 3
Serum concentrations of sVCAM-1. The measurement of sVCAM-1 was performed and shown as described in the legend to fig 2.
Figure 4
Serum concentrations of sE-selectin were analysed and presented as described in the legend to fig 2.
Figure 5
Serum concentrations of VEGF analysed and presented as described in the legend to fig 2.

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Group

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...